Estudios clínicos

[:en]New evidence on the mechanism of action of hyaluronic acid[:es]Nuevas evidencias sobre el mecanismo de acción del ácido hialurónico[:fr]NOUVELLES PREUVES SUR LE MÉCANISME D’ACTION DE L’ACIDE HYALURONIQUE[:]

[:en]Hyaluronic acid is a mucopolysaccharide present in our body, in particular in the subcutaneous tissue. For this reason, it has been widely used as a cosmetic ingredient because of its high moisturizing action. Hyaluronic acid has also been used as a drug for the treatment of articular inflammation, as it… Leer más »[:en]New evidence on the mechanism of action of hyaluronic acid[:es]Nuevas evidencias sobre el mecanismo de acción del ácido hialurónico[:fr]NOUVELLES PREUVES SUR LE MÉCANISME D’ACTION DE L’ACIDE HYALURONIQUE[:]

[:en] For probiotic administration there is no indication of amount or maximum treatment duration. Probiotics can be administered as long as desired without safety issues. Probiotic dosing varies depending on the product and specific indication. Although no official consensus exists on the minimum number of microorganism that must ingested to… Leer más »[:en]What is the maximum daily dosage of probiotics and treatment duration?[:es]¿Cuál es la cantidad máxima de probióticos al día y duración de tratamiento?[:fr]Quelle est la quantité maximale de probiotique par jour et la durée du traitement ?[:]

[:en] This year a new study was conducted with patients suffering from osteoarthritis in Los Manzanos Clinic of Logrono. The results were highly satisfactories as they demonstrated the efficacy of Ovomet® to produce a linear increase in the degree of improvement in pain, stiffness, functionality and general health of the… Leer más »[:en]Clinical study about the Ovomet®’s efficacy [:es]Estudio clínico sobre la eficacia de Ovomet®[:fr]Étude clinique sur l’efficacité d’Ovomet®[:]

[:en] Nobody doubts that It is essential for probiotics to survive GI passage and arrive alive at their site of action. The main barriers of the GI tract that probiotics encounter include: pH, composition and buffer capacity of the gastric juice, transit time and the presence of foods. The moment… Leer más »[:en]PROBIOACT® Technology in the gastro-intestinal survival of Megaflora 9[:es]La Tecnología PROBIOACT® en la supervivencia gastrointestinal de Megaflora 9[:fr]La technologie Probioact® dans la survie gastro-intestinale de Megaflora 9[:]

[:en] Gencor Pacific has recently informed us that the first clinical study with its ingredient Libifem™ has been accepted for publication in a scientific journal during 2015. Gencor has also told us that is running a new clinical study with Libifem™ in a group of 180 menopausal women. The results of… Leer más »[:en]Libifem™ clinical studies[:es]Estudios clínicos con Libifem™ [:fr]Études cliniques avec Libifem™ [:]

[:en] [:es] Anunciamos que Solchem Nature S.L.U. acaba de alcanzar un acuerdo de distribución en exclusiva para España y Portugal con el fabricante Eggnovo S.L. Esta joven empresa ubicada en Villatuerta (Navarra) es la responsable del desarrollo de una innovadora patente para la producción de membrana de huevo. Ovomet®, el… Leer más »[:es]Nuevo acuerdo de distribución exclusiva de Solchem con Eggnovo[:fr]NOUVEAU CONTRAT DE DISTRIBUTION EXCLUSIVE DE SOLCHEM AVEC EGGNOVO[:]